PGR and breast carcinoma: In breast cancer, JMJD8 inhibits type I IFN signaling by blocking STING-TBK1 complex formation [50], and progesterone receptor (PR) interacts with STAT1 to suppress IFN-induced STAT1 phosphorylation [51].